bioAffinity Technologies (BIAF) Change in Account Payables (2022 - 2025)
Historic Change in Account Payables for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to -$229076.0.
- bioAffinity Technologies' Change in Account Payables fell 25153.23% to -$229076.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $157823.0, marking a year-over-year increase of 16489.73%. This contributed to the annual value of $382521.0 for FY2024, which is 273789.39% up from last year.
- Per bioAffinity Technologies' latest filing, its Change in Account Payables stood at -$229076.0 for Q3 2025, which was down 25153.23% from -$211741.0 recorded in Q2 2025.
- In the past 5 years, bioAffinity Technologies' Change in Account Payables ranged from a high of $577474.0 in Q3 2023 and a low of -$435285.0 during Q3 2022
- In the last 4 years, bioAffinity Technologies' Change in Account Payables had a median value of $17284.0 in 2022 and averaged $29073.7.
- Its Change in Account Payables has fluctuated over the past 5 years, first plummeted by 124848.99% in 2023, then surged by 156544.3% in 2024.
- Quarter analysis of 4 years shows bioAffinity Technologies' Change in Account Payables stood at $195360.0 in 2022, then plummeted by 315.67% to -$421337.0 in 2023, then soared by 148.51% to $204373.0 in 2024, then tumbled by 212.09% to -$229076.0 in 2025.
- Its Change in Account Payables stands at -$229076.0 for Q3 2025, versus -$211741.0 for Q2 2025 and $394267.0 for Q1 2025.